174 related articles for article (PubMed ID: 29339543)
1. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
2. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.
Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R
Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397
[TBL] [Abstract][Full Text] [Related]
3. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
Court F; Arnaud P
Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment.
Gyparaki MT; Papavassiliou AG
Clin Breast Cancer; 2018 Jun; 18(3):189-191. PubMed ID: 29042129
[No Abstract] [Full Text] [Related]
5. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
6. Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer.
Bernhart SH; Kretzmer H; Holdt LM; Jühling F; Ammerpohl O; Bergmann AK; Northoff BH; Doose G; Siebert R; Stadler PF; Hoffmann S
Sci Rep; 2016 Nov; 6():37393. PubMed ID: 27876760
[TBL] [Abstract][Full Text] [Related]
7. Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes.
Lee SM; Lee J; Noh KM; Choi WY; Jeon S; Oh GT; Kim-Ha J; Jin Y; Cho SW; Kim YJ
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1885-E1894. PubMed ID: 28223506
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
[TBL] [Abstract][Full Text] [Related]
9. Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells.
Dunican DS; Mjoseng HK; Duthie L; Flyamer IM; Bickmore WA; Meehan RR
BMC Biol; 2020 Mar; 18(1):25. PubMed ID: 32131813
[TBL] [Abstract][Full Text] [Related]
10. H4K20me3 co-localizes with activating histone modifications at transcriptionally dynamic regions in embryonic stem cells.
Xu J; Kidder BL
BMC Genomics; 2018 Jul; 19(1):514. PubMed ID: 29969988
[TBL] [Abstract][Full Text] [Related]
11. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
[TBL] [Abstract][Full Text] [Related]
12. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide positioning of bivalent mononucleosomes.
Sen S; Block KF; Pasini A; Baylin SB; Easwaran H
BMC Med Genomics; 2016 Sep; 9(1):60. PubMed ID: 27634286
[TBL] [Abstract][Full Text] [Related]
14. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
15. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
Paul TA; Bies J; Small D; Wolff L
Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
[TBL] [Abstract][Full Text] [Related]
16. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling and bivalent histone modifications in embryonic stem cells.
Harikumar A; Meshorer E
EMBO Rep; 2015 Dec; 16(12):1609-19. PubMed ID: 26553936
[TBL] [Abstract][Full Text] [Related]
18. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
McGarvey KM; Van Neste L; Cope L; Ohm JE; Herman JG; Van Criekinge W; Schuebel KE; Baylin SB
Cancer Res; 2008 Jul; 68(14):5753-9. PubMed ID: 18632628
[TBL] [Abstract][Full Text] [Related]
19. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
[TBL] [Abstract][Full Text] [Related]
20. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Kwon MJ; Kim SS; Choi YL; Jung HS; Balch C; Kim SH; Song YS; Marquez VE; Nephew KP; Shin YK
Carcinogenesis; 2010 Jun; 31(6):974-83. PubMed ID: 20053926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
